Health Services Research
Latest posts by Health Services Research (see all)
- The Impact of Pediatrician Supply on Child Health Outcomes: Longitudinal Evidence from Japan - Sep. 01, 2015
- Determinants of Private Long-Term Care Insurance Purchase in Response to the Partnership… - Aug. 25, 2015
- Falsification Testing of Instrumental Variables Methods for Comparative Effectiveness Research - Aug. 21, 2015
- Patient Preferences for Features of Health Care Delivery Systems: A Discrete Choice Experiment - Aug. 10, 2015
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: